Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant Glioma

被引:157
作者
Braun, Christian J. [1 ,2 ]
Stanciu, Monica [1 ,2 ]
Boutz, Paul L. [1 ,2 ]
Patterson, Jesse C. [1 ,2 ]
Calligaris, David [3 ]
Higuchi, Fumi [4 ]
Neupane, Rachit [1 ,2 ]
Fenoglio, Silvia [1 ,2 ]
Cahill, Daniel P. [4 ]
Wakimoto, Hiroaki [4 ]
Agar, Nathalie Y. R. [3 ,5 ,6 ]
Yaffe, Michael B. [1 ,2 ,7 ,8 ]
Sharp, Phillip A. [1 ,2 ]
Hemann, Michael T. [1 ,2 ]
Lees, Jacqueline A. [1 ,2 ]
机构
[1] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA
[2] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA
[4] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02115 USA
[5] Harvard Med Sch, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA
[6] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA
[7] MIT, Dept Biol Engn, Cambridge, MA 02139 USA
[8] Harvard Med Sch, Div Acute Care Surg Trauma & Crit Care, Dept Surg, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
关键词
PRMT5 ARGININE METHYLTRANSFERASE; PRE-MESSENGER-RNA; IN-VIVO; TEMOZOLOMIDE; MODELS; SMN;
D O I
10.1016/j.ccell.2017.08.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Glioblastoma (GBM) is a devastating malignancy with few therapeutic options. We identify PRMT5 in an in vivo GBM shRNA screen and show that PRMT5 knockdown or inhibition potently suppresses in vivo GBM tumors, including patient-derived xenografts. Pathway analysis implicates splicing in cellular PRMT5 dependency, and we identify a biomarker that predicts sensitivity to PRMT5 inhibition. We find that PRMT5 deficiency primarily disrupts the removal of detained introns (DIs). This impaired DI splicing affects proliferation genes, whose downregulation coincides with cell cycle defects, senescence and/or apoptosis. We further show that DI programs are evolutionarily conserved and operate during neurogenesis, suggesting that they represent a physiological regulatory mechanism. Collectively, these findings reveal a PRMT5-regulated DI-splicing program as an exploitable cancer vulnerability.
引用
收藏
页码:411 / +
页数:27
相关论文
共 60 条
[1]   Promoter directionality is controlled by U1 snRNP and polyadenylation signals [J].
Almada, Albert E. ;
Wu, Xuebing ;
Kriz, Andrea J. ;
Burge, Christopher B. ;
Sharp, Phillip A. .
NATURE, 2013, 499 (7458) :360-U141
[2]   Differential expression analysis for sequence count data [J].
Anders, Simon ;
Huber, Wolfgang .
GENOME BIOLOGY, 2010, 11 (10)
[3]   Detecting differential usage of exons from RNA-seq data [J].
Anders, Simon ;
Reyes, Alejandro ;
Huber, Wolfgang .
GENOME RESEARCH, 2012, 22 (10) :2008-2017
[4]   Crystal structure of the human PRMT5:MEP50 complex [J].
Antonysamy, Stephen ;
Bonday, Zahid ;
Campbell, Robert M. ;
Doyle, Brandon ;
Druzina, Zhanna ;
Gheyi, Tarun ;
Han, Bomie ;
Jungheim, Louis N. ;
Qian, Yuewei ;
Rauch, Charles ;
Russell, Marijane ;
Sauder, J. Michael ;
Wasserman, Stephen R. ;
Weichert, Kenneth ;
Willard, Francis S. ;
Zhang, Aiping ;
Emtage, Spencer .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (44) :17960-17965
[5]   The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity [J].
Barretina, Jordi ;
Caponigro, Giordano ;
Stransky, Nicolas ;
Venkatesan, Kavitha ;
Margolin, Adam A. ;
Kim, Sungjoon ;
Wilson, Christopher J. ;
Lehar, Joseph ;
Kryukov, Gregory V. ;
Sonkin, Dmitriy ;
Reddy, Anupama ;
Liu, Manway ;
Murray, Lauren ;
Berger, Michael F. ;
Monahan, John E. ;
Morais, Paula ;
Meltzer, Jodi ;
Korejwa, Adam ;
Jane-Valbuena, Judit ;
Mapa, Felipa A. ;
Thibault, Joseph ;
Bric-Furlong, Eva ;
Raman, Pichai ;
Shipway, Aaron ;
Engels, Ingo H. ;
Cheng, Jill ;
Yu, Guoying K. ;
Yu, Jianjun ;
Aspesi, Peter, Jr. ;
de Silva, Melanie ;
Jagtap, Kalpana ;
Jones, Michael D. ;
Wang, Li ;
Hatton, Charles ;
Palescandolo, Emanuele ;
Gupta, Supriya ;
Mahan, Scott ;
Sougnez, Carrie ;
Onofrio, Robert C. ;
Liefeld, Ted ;
MacConaill, Laura ;
Winckler, Wendy ;
Reich, Michael ;
Li, Nanxin ;
Mesirov, Jill P. ;
Gabriel, Stacey B. ;
Getz, Gad ;
Ardlie, Kristin ;
Chan, Vivien ;
Myer, Vic E. .
NATURE, 2012, 483 (7391) :603-607
[6]   The SMN complex: An assembly machine for RNPs [J].
Battle, D. J. ;
Kasim, M. ;
Yong, J. ;
Lotti, F. ;
Lau, C.-K. ;
Mouaikel, J. ;
Zhang, Z. ;
Han, K. ;
Wan, L. ;
Dreyfuss, G. .
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 2006, 71 :313-320
[7]   Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery [J].
Bezzi, Marco ;
Teo, Shun Xie ;
Muller, Julius ;
Mok, Wei Chuen ;
Sahu, Sanjeeb Kumar ;
Vardy, Leah A. ;
Bonday, Zahid Q. ;
Guccione, Ernesto .
GENES & DEVELOPMENT, 2013, 27 (17) :1903-1916
[8]   Symmetrical dimethylarginine methylation is required for the localization of SMN in Cajal bodies and pre-mRNA splicing [J].
Boisvert, FM ;
Côté, J ;
Boulanger, MC ;
Cléroux, P ;
Bachand, F ;
Autexier, C ;
Richard, S .
JOURNAL OF CELL BIOLOGY, 2002, 159 (06) :957-969
[9]   Detained introns are a novel, widespread class of post-transcriptionally spliced introns [J].
Boutz, Paul L. ;
Bhutkar, Arjun ;
Sharp, Phillip A. .
GENES & DEVELOPMENT, 2015, 29 (01) :63-80
[10]   Rewiring the solid tumor epigenome for cancer therapy [J].
Braun, Christian J. ;
Hemann, Michael T. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (09) :977-987